RNF43

gene product
DKFZp781H0392, FLJ20315, URCC
The protein encoded by this gene is a RING-type E3 ubiquitin ligase and is predicted to contain a transmembrane domain, a protease-associated domain, an ectodomain, and a cytoplasmic RING domain. This protein is thought to negatively regulate Wnt signaling, and expression of this gene results in an increase in ubiquitination of frizzled receptors, an alteration in their subcellular distribution, resulting in reduced surface levels of these receptors. Mutations in this gene have been reported in multiple tumor cells, including colorectal and endometrial cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
173 antibodies from 23 providers.

Antibody properties

General

Applications

or Cancel
Antibody
LifeSpan BioSciences, Inc.
21 antibodies
NSJ Bioreagents
2 antibodies
Aviva Systems Biology
2 antibodies
Abgent
1 antibody
Atlas Antibodies
1 antibody
antibodies-online
52 antibodies
Biorbyt
21 antibodies
Invitrogen Antibodies
2 antibodies
Abiocode, Inc.
6 antibodies
ProSci
2 antibodies
Boster Biological Technology
1 antibody
Creative Biolabs
8 antibodies
Novus Biologicals
9 antibodies
GeneTex
2 antibodies
OriGene
2 antibodies
R&D Systems
8 antibodies
Abnova Corporation
1 antibody
NovoPro Bioscience Inc.
2 antibodies
MyBioSource
1 antibody
United States Biological
13 antibodies
Creative Diagnostics
2 antibodies
Sigma-Aldrich
2 antibodies